G7 vaccines failures contribute to 600,000 preventable deaths  

Publié: 25th juin 2022

Latest data suggests rich countries are likely to have already secured majority of next generation COVID vaccines

Less than half (49 percent) of the 2.1 billion COVID vaccine donations promised to poorer countries by G7 countries have been delivered, according to new figures published today by Oxfam and the People’s Vaccine Alliance.   
On the eve of this year’s G7 Summit, taking place in the German Alps, a new analysis shows that had the missing donated doses been shared in 2021, it could have been enough to save almost 600,000 lives in low- and middle-income countries, the equivalent of one every minute.  
The worst offenders are the UK and Canada, who have failed to deliver anywhere near the number of vaccines they promised. Just 39 percent of the100 million doses the UK pledged to deliver by the end of this month have actually been delivered. While the deadline to meet their respective commitments isn’t until the end of the year, only 30 percent of Canada’s 50.7 million doses and 46 percent of the 1.2 billion pledged by the US have been delivered. So-called ‘Team Europe’ have collectively delivered just 56 percent of the 700 million doses promised by the middle of 2022 and Japan has delivered 64 percent of the 60 million doses it said it would send.   
Latest data from Airfinity suggests that rich nations may have already secured over half (55 percent) of the new generation of Omicron-specific mRNA COVID-19 vaccines being developed by Moderna and Pfizer/BioNTech. This is even before they have been approved for use, making it likely that many developing countries will yet again be left at the back of the queue.  
Max Lawson, Head of Inequality Policy at Oxfam and Co-Chair of the People’s Vaccine Alliance, said: “On every level, rich nations have massively betrayed poor countries when it comes to COVID vaccines. First, they stockpiled all the supply for themselves, then they promised to donate their leftovers, but hundreds of millions of these doses never materialized. 
“Rich nations are already hoarding the new generation of Omicron specific vaccines, whilst people in poorer countries will be forced to continue to face new variants with vaccines that are increasingly ineffective. The only way to fix this is to give nations the rights to make their own, not rely on rich countries to pass on doses they no longer need and deliver too late for the millions who have died.”  
New data published yesterday by Imperial College London found that 599,300 deaths could have been averted in 2021 had 40 percent of people in all countries been fully vaccinated. The billion missing doses that G7 countries failed to deliver would have been enough to reach this target. Nearly all these preventable deaths were in low- and middle-income countries.   
To date only 14 percent of people in low-income countries and 18 percent of people on the African continent are fully vaccinated – far from the target to have 70 percent coverage in all nations by the middle of the year.  Despite such low vaccine coverage, the Imperial College research found COVID vaccines have saved 446,400 lives in Africa and 180,300 in low-income countries 
At the same time, rich nations led by the EU and UK have forced through a text at the WTO which has failed to waive intellectual property on vaccines, treatments and technology that would have enabled developing countries to produce their own generic vaccines. Instead, the text adds even more bureaucratic hurdles and further protects the hugely profitable monopolies of firms such as Pfizer/BioNTech and Moderna. The People’s Vaccine Alliance is calling on all countries facing shortages of vaccines, tests and treatments to save lives and end the pandemic by using all trade rule flexibilities available and circumventing WTO rules if necessary. They say the G7 and other rich countries must not stand in their way.   
The campaign groups also says that the model of leaving developing countries to rely on donations in order to vaccinate people is completely flawed and actually leads to frustration and mistrust.   
Julia Kosgei, Policy Advisor at The People’s Vaccine Alliance said: “Hundreds of thousands of lives have been saved in Africa by the vaccines, but so many more deaths could have been prevented. Vaccination programs have worked best when doses have arrived on time, allowing governments to plan and scale up distribution. But many countries waited a year to get their first doses. When doses finally arrived, they came all at once, often close to their expiry date, which is totally unmanageable and unfair for countries that have already struggling health systems.  
“Developing countries do not want to have to wait for leftovers, they want the reliability and dignity of being able to produce their own doses. It is a disgrace that rich countries stalled negotiations on an IP waiver to scale up vaccine production across the world so that pharmaceutical corporations could maximise profits while people died without access. To add insult to injury they couldn't even be bothered to ensure timely access to the doses they didn't even need.  
“Rich countries have demonstrated that they cannot be trusted to act in the interests of public health for everyone, everywhere - it's time for leaders from the global South to take matters into their own hands. We hope that governments will do whatever is needed to protect their populations – whether that is using flexibilities in global intellectual property rules or circumventing them to save lives. Rich countries must not get in their way.”  
Previous research by the People’s Vaccine Alliance found that vaccine monopolies are making it five times more expensive to vaccinate the world, while Moderna and Pfizer/BioNTech are making over $1,000 profit every second from COVID vaccines.  

Notes aux rédactions

On Saturday 25 June an Oxfam ‘Big Heads’ photo opportunity will be taking place from 10:30 am local time in Munich. Campaigners dressed as G7 leaders in hiking outfits will have to choose the right path to fight the COVID pandemic, standing at a big signpost with two directions, towards “Corporate profits” or “Saving lives”. For more information, please see the media advisory.
G7 donations  
The figures for the deliveries of donated vaccines to date were sourced from Airfinity’s non-public database, on 9th June 2022. Pledges are sourced below and are a combination of the pledges made at the 2021 G7 summit as well as subsequent commitments and only includes physical dose donations. 1,071,932,390 pledged Covid-19 doses are yet to be delivered.  

Country Total deliveries to date of COVID-19 vaccine doses Pledged % By when Pledge source 
Canada    15,441,410    50,700,000  30% End of 2022 https://www.doctorswithoutborders.ca/article/uphold-its-covid-19-vaccine-donation-pledge-canada-must-showthereceipts
Japan   38,477,570  60,000,000  64%  Not stated  https://www.mofa.go.jp/ic/ghp/page4e_001165.html
United Kingdom  39,090,930  100,000,000 39% By June 2022   https://www.gov.uk/government/news/uk-to-donate-100-million-coronavirus-vaccine-doses
United States 550,668,340    1,200,000,000   46%  Before 2023   https://www.state.gov/covid-19-recovery/vaccine-deliveries/
Team Europe  395,089,360   700,000,000    56% Mid-2022  https://www.consilium.europa.eu/en/policies/coronavirus/global-solidarity/
Total 1,038,767,610    2,110,700,000 49%    
Country Delivered Pledged % By when Pledge source
France 67,943,110 120,000,000 57%  Middle of 2022  https://www.thinkglobalhealth.org/article/billions-committed-millions-delivered
Germany 116,316,360    175,000,000  66% End of 2022  http://https/www.auswaertiges-amt.de/de/aussenpolitik/themen/gesundheit/pandemie-bekaempfung
Italy 56,112,160   100,700,000  56% Not stated  https://tg24.sky.it/salute-e-benessere/2022/05/12/italia-covid-vaccini-draghi

Team Europe is the vaccine initiative that includes all EU Member States as well as in Iceland, Liechtenstein and Norway. Individual EU countries have made their own pledges which are part of the 700 million dose target.  
Preventable deaths  
A new study published on 23 June by Imperial College London, found that between 8 December 2020 to 8 December 2021, 599,300 additional deaths would have been averted if countries had met the WHO target of 40 percent of all populations being fully vaccinated.   

Income group Number of deaths that could have been averted at 40% target
High Income   20 
Upper middle income  51,110  
Lower middle income 347,500 
Low income 200,000 

There are 525,600 minutes in a year and so there were 1.14 preventable deaths per minute in low- and middle-income countries. Taking into account those who are partially and fully vaccinated, according to data from Our World in Data, analyzed by Oxfam, 961,963,161 doses were needed in low- and middle-income countries at the end of 2022 to reach the 40 percent target – assuming everyone has two vaccine doses. The missing doses pledge by G7 countries is 1,071,932,390. The deaths averted assumes that the G7 would have met their pledges during 2021 – many of the pledges are for delivery by the end of 2022.  
Omicron specific vaccines   
Analysis of the vaccine orders made with vaccine manufactures and projected production of new generation Omicron-specific mRNA vaccines for 2022 according to Airfinity found an estimated 61 percent of Pfizer/BioNTech’s projected 409 million new Omicron-specific mRNA vaccines and 36 percent of Moderna’s projected 113 million new generation Omicron-specific mRNA vaccines will ship to high-income countries – assuming new vaccines produced this year are distributed in the same proportions as overall 2022 supply proportions – for a total of 55 percent of overall supply of new generation mRNA COVID-19 vaccines going to high-income countries in 2022.   
Cost of vaccine monopolies   
"The Great Vaccine Robbery" report sets out the excessive prices being charged by some pharmaceutical companies for COVID-19 vaccines. Oxfam calculated that Pfizer, BioNTech and Moderna make $1,000 profit every second


Sarah Dransfield in the UK | media.unit@oxfam.org.uk | +44 (0)7884 114825 
Annie Thériault in Peru | annie.theriault@oxfam.org | +51 936 307 990

For updates, please follow @NewsFromOxfam and @Oxfam

Please support Oxfam's Coronavirus Response Appeal.